{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:24:50Z","timestamp":1782491090327,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,12,12]],"date-time":"2008-12-12T00:00:00Z","timestamp":1229040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1245\/s10434-008-0219-1","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T15:33:23Z","timestamp":1229009603000},"page":"463-472","source":"Crossref","is-referenced-by-count":45,"title":["Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)"],"prefix":"10.1245","volume":"16","author":[{"given":"D.","family":"Baratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Cabras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dileo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Laterza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,12]]},"reference":[{"key":"219_CR1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/annonc\/mdl060","volume":"17","author":"R Hassan","year":"2006","unstructured":"Hassan R, Alexander R, Antman K, et\u00a0al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006;17:1615\u20139.","journal-title":"Ann Oncol"},{"key":"219_CR2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985\u201390.","journal-title":"Ann Oncol"},{"key":"219_CR3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591\u2013603.","journal-title":"N Engl J Med"},{"key":"219_CR4","first-page":"453","volume":"29","author":"N Zaffaroni","year":"2007","unstructured":"Zaffaroni N, Costa A, Pennati M, et\u00a0al. Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma. Cell Oncol. 2007;29:453\u201366.","journal-title":"Cell Oncol"},{"key":"219_CR5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.onc.1209809","volume":"26","author":"AC Borczuk","year":"2007","unstructured":"Borczuk AC, Cappellini GCA, Kim HK, et\u00a0al. Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumor. Oncogene. 2007;26:610\u20137.","journal-title":"Oncogene"},{"key":"219_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","volume":"7","author":"PA Janne","year":"2005","unstructured":"Janne PA, Wozniak AJ, Belani CP, et\u00a0al. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer. 2005;7:40\u20136.","journal-title":"Clin Lung Cancer"},{"key":"219_CR7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/000313480106701019","volume":"67","author":"BW Loggie","year":"2001","unstructured":"Loggie BW, Fleming RA, McQuellon RP, et\u00a0al. Prospective trial for the treatment of malignant peritoneal mesothelioma, Am Surg. 2001;67:999\u20131003.","journal-title":"Am Surg"},{"key":"219_CR8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1055-3207(03)00045-0","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH, Welch LS, Mohamed F, et\u00a0al. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin North Am. 2003;12:605\u201321.","journal-title":"Surg Oncol Clin North Am"},{"key":"219_CR9","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF, et\u00a0al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003;21:4560\u20137.","journal-title":"J Clin Oncol"},{"key":"219_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","volume":"13","author":"C Brigand","year":"2006","unstructured":"Brigand C, Monneuse O, Mohamed F, et\u00a0al. Malignant peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal chemohyperthermia: results of a prospective study. Ann Surg Oncol. 2006;13:405\u201312.","journal-title":"Ann Surg Oncol"},{"key":"219_CR11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco M, Nonaka D, Baratti D, et\u00a0al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2006;13:229\u201337.","journal-title":"Ann Surg Oncol"},{"key":"219_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Brun EA, Cerruto CA, et\u00a0al. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2007;14:41\u20139.","journal-title":"Ann Surg Oncol"},{"key":"219_CR13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01225271","volume":"118","author":"M Markman","year":"1992","unstructured":"Markman M, Kelsen D. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol. 1992;118:547\u201350.","journal-title":"J Cancer Res Clin Oncol"},{"key":"219_CR14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002920050340","volume":"20","author":"V Neumann","year":"1999","unstructured":"Neumann V, Muller KM, Fischer M. Peritoneal mesothelioma\u2014incidence and aetiology. Pathologe. 1999;20:169\u201376.","journal-title":"Pathologe"},{"key":"219_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","volume":"70","author":"GH Eltabbakh","year":"1999","unstructured":"Eltabbakh GH, Piver MS, Hempling RE, et\u00a0al. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol. 1999;70:6\u201312.","journal-title":"J Surg Oncol"},{"key":"219_CR16","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0959-8049(96)00178-5","volume":"32","author":"FAN Zoetmulder","year":"1996","unstructured":"Zoetmulder FAN, Sugarbaker PH. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer. 1996;32:1727\u201333.","journal-title":"Eur J Cancer"},{"key":"219_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/ASO.2004.08.014","volume":"11","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, Boot H, Aleman BM, et\u00a0al. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004;11:375\u20139.","journal-title":"Ann Surg Oncol"},{"key":"219_CR18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1245\/s10434-006-9174-x","volume":"14","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, et\u00a0al. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome. Ann Surg Oncol. 2007;14:493\u20139.","journal-title":"Ann Surg Oncol"},{"key":"219_CR19","doi-asserted-by":"crossref","unstructured":"Bjelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. May 15;[Epub ahead of print].","DOI":"10.1245\/s10434-007-9410-z"},{"key":"219_CR20","doi-asserted-by":"crossref","unstructured":"Yan TD, Bjelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007 June 1;[Epub ahead of print].","DOI":"10.1245\/s10434-007-9462-0"},{"key":"219_CR21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21239","volume":"104","author":"D Nonaka","year":"2005","unstructured":"Nonaka D, Kusamura S, Baratti D, et\u00a0al. Diffuse malignant mesothelioma of the peritoneum. Cancer. 2005;104:2181\u20138.","journal-title":"Cancer"},{"key":"219_CR22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et\u00a0al. Toxicity and response criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"219_CR23","first-page":"321","volume":"1","author":"JE Esquivel","year":"1998","unstructured":"Esquivel JE, Sugarbaker PH. Elective surgery in recurrent colon cancer with peritoneal seeding: when to and when not to. Cancer Ther. 1998;1:321\u20135.","journal-title":"Cancer Ther"},{"key":"219_CR24","first-page":"49","volume":"15","author":"P Jaquet","year":"1996","unstructured":"Jaquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49\u201358.","journal-title":"J Exp Clin Cancer Res"},{"key":"219_CR25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cncr.10176","volume":"94","author":"CR Rossi","year":"2002","unstructured":"Rossi CR, Foletto M, Mocellin S, et\u00a0al. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer. 2002;94:492\u20139.","journal-title":"Cancer"},{"key":"219_CR26","unstructured":"Battifora H, McCaughey WTE. Tumors of the Serosal Membranes. Washington, DC: Armed Forces Institute of Pathology; 1994. Atlas of Tumor Pathology; 3rd series, fascicle 15."},{"key":"219_CR27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00000478-199510000-00003","volume":"19","author":"J Goldblum","year":"1995","unstructured":"Goldblum J, Hart WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol. 1995;19:1124\u201337.","journal-title":"Am J Surg Pathol"},{"key":"219_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, et\u00a0al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"219_CR29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.20836","volume":"103","author":"TD Yan","year":"2005","unstructured":"Yan TD, Haveric N, Carmignani CP, et\u00a0al. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer. 2005;103:839\u201349.","journal-title":"Cancer"},{"key":"219_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc. 1958;53:457\u201381.","journal-title":"J Am Stat Soc"},{"key":"219_CR31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187\u2013220.","journal-title":"J R Stat Soc B"},{"key":"219_CR32","first-page":"3380","volume":"48","author":"G Los","year":"1989","unstructured":"Los G, Mutsaers PH, van der Vijgh WJ, et\u00a0al. Direct diffusion of cis-platinum in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res. 1989;48:3380\u20134.","journal-title":"Cancer Res"},{"key":"219_CR33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","volume":"18","author":"T Yan","year":"2007","unstructured":"Yan T, Welch L, Black D, et\u00a0al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827\u201334.","journal-title":"Ann Oncol"},{"key":"219_CR34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2168.2002.01967.x","volume":"89","author":"PH Sugarbaker","year":"2002","unstructured":"Sugarbaker PH. Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Br J Surg. 2002;89:208\u201312.","journal-title":"Br J Surg"},{"issue":"suppl","key":"219_CR35","first-page":"P75","volume":"14","author":"M Gann","year":"2007","unstructured":"Gann M, Pitroff A, Esquivel J. prospective comparison of the peritoneal cancer index at the time of surgery in 28 patients with peritoneal surface malignancies. Ann Surg Oncol. 2007;14(supl):P75.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-0219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-008-0219-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-0219-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T04:10:22Z","timestamp":1738815022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-008-0219-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,12]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1245\/s10434-008-0219-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,12]]}}}